OTC Markets OTCPK - Delayed Quote USD
Surgical Science Sweden AB (publ) (SUSRF)
14.79
0.00
(0.00%)
At close: May 19 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
946,535
884,087
882,853
802,540
366,778
Cost of Revenue
299,363
286,189
269,974
271,023
100,836
Gross Profit
647,172
597,898
612,879
531,517
265,942
Operating Expense
504,888
453,576
423,727
368,980
209,419
Operating Income
142,284
144,322
189,152
162,537
56,523
Net Non Operating Interest Income Expense
38,689
18,278
64,070
45,636
17,546
Pretax Income
176,466
158,093
268,264
208,173
65,804
Tax Provision
35,374
26,446
34,292
20,199
-20,444
Net Income Common Stockholders
141,091
131,646
233,972
187,974
86,248
Diluted NI Available to Com Stockholders
141,091
131,646
233,972
187,974
86,248
Basic EPS
2.76
--
4.59
3.70
2.03
Diluted EPS
2.76
--
4.59
3.69
2.02
Basic Average Shares
51,026.24
--
50,929.36
50,801.24
42,488.25
Diluted Average Shares
51,026.24
--
50,940.78
50,913.94
42,669.28
Total Operating Income as Reported
142,282
144,320
189,152
162,537
56,523
Total Expenses
804,251
739,765
693,701
640,003
310,255
Net Income from Continuing & Discontinued Operation
141,091
131,646
233,972
187,974
86,248
Normalized Income
141,312.47
131,876.66
233,972
187,974
86,248
Interest Income
--
23,958
64,726
46,941
18,368
Interest Expense
--
5,680
656
1,305
822
Net Interest Income
38,689
18,278
64,070
45,636
17,546
EBIT
161,735
163,773
268,920
209,478
66,626
EBITDA
161,735
224,287
324,533
261,063
100,143
Reconciled Cost of Revenue
299,363
286,189
269,974
271,023
100,836
Reconciled Depreciation
--
60,514
55,613
51,585
33,517
Net Income from Continuing Operation Net Minority Interest
141,091
131,646
233,972
187,974
86,248
Total Unusual Items Excluding Goodwill
-277
-277
0
0
0
Total Unusual Items
-277
-277
0
0
0
Normalized EBITDA
162,012
224,564
324,533
261,063
100,143
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-55.53
-46.34
0
0
0
12/31/2021 - 1/21/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade